Although CRISPR-based gene therapy for sickle cell disease offers transformative outcomes, drugmakers are striving to develop treatments that are easy to manufacture and can reach much larger numbers of patients.

中文翻译：

---

创新者想要治疗镰状细胞病的药物。它们能与基因疗法相匹配吗？

尽管基于 CRISPR 的镰状细胞病基因疗法提供了变革性的结果，但制药商正在努力开发易于生产且可以惠及更多患者的治疗方法。